Viagra, or sildenafil, primarily works by inhibiting phosphodiesterase-5 (PDE5). PDE5 is an enzyme that breaks down cyclic guanosine monophosphate (cGMP), a crucial molecule for blood vessel relaxation.
Increased cGMP Levels
By blocking PDE5, Viagra allows cGMP levels to increase. Higher cGMP levels trigger the relaxation of smooth muscles in the blood vessels of the penis, leading to increased blood flow.
The Role of Nitric Oxide
This process is initiated by nitric oxide (NO), a neurotransmitter released during sexual stimulation. NO stimulates the production of cGMP. Viagra enhances the effects of NO by preventing the rapid breakdown of cGMP.
Blood Vessel Response
The increased blood flow resulting from vasodilation fills the erectile tissues, causing an erection. This mechanism isn’t exclusive to penile tissue; Viagra can affect other blood vessels as well, though the effects are most pronounced in the penis.
Simplified Summary
| 1 | Sexual stimulation releases nitric oxide (NO). |
| 2 | NO increases cGMP levels. |
| 3 | Viagra inhibits PDE5, preventing cGMP breakdown. |
| 4 | Elevated cGMP causes blood vessel relaxation (vasodilation). |
| 5 | Increased blood flow leads to an erection. |
Specific Considerations
While Viagra primarily targets PDE5, it can, at higher doses, affect other PDE isoforms, potentially leading to side effects. Individual responses vary; factors like age, underlying health conditions, and concurrent medications influence the drug’s effects.
